Imagion Biosystems Limited (ASX:IBX)

Revenue by Product

Financials in millions AUD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Research & Development	1.16M
Research & Development Growth	7.14%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
United States	1.21M
United States Growth	11.59%
Australia	1.02M